Juliette Sallé, Marie-Anne Brundler, Renee Perrier, Mary Brindle, Lucie Lafay-Cousin
{"title":"Association of gestational choriocarcinoma in a mother and Li-Fraumeni syndrome in her child: The result of a single event?","authors":"Juliette Sallé, Marie-Anne Brundler, Renee Perrier, Mary Brindle, Lucie Lafay-Cousin","doi":"10.1007/s10689-026-00573-0","DOIUrl":null,"url":null,"abstract":"<p><p>Li-Fraumeni Syndrome (LFS) is a cancer predisposition syndrome caused by germline TP53 mutations. LFS is typically inherited but can also arise de novo. In children with LFS, the most common malignancies are adrenocortical carcinomas, brain tumors, and soft tissue sarcomas. Herein, we present a 5.5-year-old girl with a novel TP53 germline mutation (NM_000546.4, c.132_147dup; p.Ile50Alafs*7) associated with an unusual and aggressive oncologic phenotype in the context of LFS. Over five years, the patient successively developed undifferentiated sarcoma, Burkitt lymphoma and extra-skeletal osteosarcoma. There was no family history of LFS, but the proband's mother had died shortly after her pregnancy from a gestational choriocarcinoma caused by the same TP53 mutation as the proband. We present the first case of a TP53 mutation from non-carrier parents affecting both mother and child to date. We describe the pathogenic variant and the possible mechanism underlying the co-occurrence of the proband's LFS and her mother's gestational choriocarcinoma.</p>","PeriodicalId":12336,"journal":{"name":"Familial Cancer","volume":"25 2","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2026-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Familial Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10689-026-00573-0","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0
Abstract
Li-Fraumeni Syndrome (LFS) is a cancer predisposition syndrome caused by germline TP53 mutations. LFS is typically inherited but can also arise de novo. In children with LFS, the most common malignancies are adrenocortical carcinomas, brain tumors, and soft tissue sarcomas. Herein, we present a 5.5-year-old girl with a novel TP53 germline mutation (NM_000546.4, c.132_147dup; p.Ile50Alafs*7) associated with an unusual and aggressive oncologic phenotype in the context of LFS. Over five years, the patient successively developed undifferentiated sarcoma, Burkitt lymphoma and extra-skeletal osteosarcoma. There was no family history of LFS, but the proband's mother had died shortly after her pregnancy from a gestational choriocarcinoma caused by the same TP53 mutation as the proband. We present the first case of a TP53 mutation from non-carrier parents affecting both mother and child to date. We describe the pathogenic variant and the possible mechanism underlying the co-occurrence of the proband's LFS and her mother's gestational choriocarcinoma.
期刊介绍:
In recent years clinical cancer genetics has become increasingly important. Several events, in particular the developments in DNA-based technology, have contributed to this evolution. Clinical cancer genetics has now matured to a medical discipline which is truly multidisciplinary in which clinical and molecular geneticists work together with clinical and medical oncologists as well as with psycho-social workers.
Due to the multidisciplinary nature of clinical cancer genetics most papers are currently being published in a wide variety of journals on epidemiology, oncology and genetics. Familial Cancer provides a forum bringing these topics together focusing on the interests and needs of the clinician.
The journal mainly concentrates on clinical cancer genetics. Most major areas in the field shall be included, such as epidemiology of familial cancer, molecular analysis and diagnosis, clinical expression, treatment and prevention, counselling and the health economics of familial cancer.